Follow
Prof. Dr. med. Thomas FE Barth
Prof. Dr. med. Thomas FE Barth
Pathology
Verified email at uniklinik-ulm.de
Title
Cited by
Cited by
Year
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
M Hummel, S Bentink, H Berger, W Klapper, S Wessendorf, TFE Barth, ...
New England Journal of Medicine 354 (23), 2419-2430, 2006
11872006
T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance
U Kintscher, M Hartge, K Hess, A Foryst-Ludwig, M Clemenz, M Wabitsch, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (7), 1304-1310, 2008
9042008
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
H Horn, M Ziepert, C Becher, TFE Barth, HW Bernd, AC Feller, W Klapper, ...
Blood, The Journal of the American Society of Hematology 121 (12), 2253-2263, 2013
6332013
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
JA Müller, R Groß, C Conzelmann, J Krüger, U Merle, J Steinhart, T Weil, ...
Nature metabolism 3 (2), 149-165, 2021
4932021
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
S Sander, L Bullinger, K Klapproth, K Fiedler, HA Kestler, TFE Barth, ...
Blood, The Journal of the American Society of Hematology 112 (10), 4202-4212, 2008
4692008
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation
MA Weniger, I Melzner, CK Menz, S Wegener, AJ Bucur, K Dorsch, ...
Oncogene 25 (18), 2679-2684, 2006
4012006
Interleukin 21–induced granzyme B–expressing B cells infiltrate tumors and regulate T cells
S Lindner, K Dahlke, K Sontheimer, M Hagn, C Kaltenmeier, TFE Barth, ...
Cancer research 73 (8), 2468-2479, 2013
3672013
Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network
E Hoster, A Rosenwald, F Berger, HW Bernd, S Hartmann, ...
Journal of Clinical Oncology 34 (12), 1386-1394, 2016
3662016
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2
S Joos, CK Menz, G Wrobel, R Siebert, S Gesk, S Ohl, G Mechtersheimer, ...
Blood, The Journal of the American Society of Hematology 99 (4), 1381-1387, 2002
3022002
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line
I Melzner, AJ Bucur, S Brüderlein, K Dorsch, C Hasel, TFE Barth, ...
Blood 105 (6), 2535-2542, 2005
2672005
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
G Ott, M Ziepert, W Klapper, H Horn, M Szczepanowski, HW Bernd, ...
Blood, The Journal of the American Society of Hematology 116 (23), 4916-4925, 2010
2552010
Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2
U Pannicke, M Hönig, I Hess, C Friesen, K Holzmann, EM Rump, TF Barth, ...
Nature genetics 41 (1), 101-105, 2009
2482009
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma
TFE Barth, JI Martin-Subero, S Joos, CK Menz, C Hasel, ...
Blood, The Journal of the American Society of Hematology 101 (9), 3681-3686, 2003
2322003
Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical …
AM Staiger, M Ziepert, H Horn, DW Scott, TFE Barth, HW Bernd, AC Feller, ...
Journal of clinical oncology 35 (22), 2515-2526, 2017
2222017
Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells
J Strater, U Wedding, TF Barth, K Koretz, C Elsing, P Moller
Gastroenterology 110 (6), 1776-1784, 1996
2141996
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2
S Joos, M Granzow, H Holtgreve‐Grez, R Siebert, L Harder, ...
International journal of cancer 103 (4), 489-495, 2003
2032003
Gain of chromosome arm 9p is characteristic of primary mediastinal B‐cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line
M Bentz, TFE Barth, S Brüderlein, D Bock, MJ Schwerer, M Baudis, S Joos, ...
Genes, Chromosomes and Cancer 30 (4), 393-401, 2001
1932001
t (11; 14)‐positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B‐cell chronic lymphocytic leukemia
M Bentz, A Plesch, L Bullinger, S Stilgenbauer, G Ott, ...
Genes, Chromosomes and Cancer 27 (3), 285-294, 2000
1912000
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome
D Kienle, A Kröber, T Katzenberger, G Ott, E Leupolt, TFE Barth, ...
Blood 102 (8), 3003-3009, 2003
1812003
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
TFE Barth, F Leithäuser, S Joos, M Bentz, P Möller
The lancet oncology 3 (4), 229-234, 2002
1742002
The system can't perform the operation now. Try again later.
Articles 1–20